• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安慰剂治疗在临床实践中的合法性:证据与伦理。

The legitimacy of placebo treatments in clinical practice: evidence and ethics.

机构信息

Department of Bioethics Clinical Center, National Institutes of Health, Bethesda, MD 20892-1156, USA.

出版信息

Am J Bioeth. 2009 Dec;9(12):39-47. doi: 10.1080/15265160903316263.

DOI:10.1080/15265160903316263
PMID:20013499
Abstract

Physicians commonly recommend 'placebo treatments', which are not believed to have specific efficacy for the patient's condition. Motivations for placebo treatments include complying with patient expectations and promoting a placebo effect. In this article, we focus on two key empirical questions that must be addressed in order to assess the ethical legitimacy of placebo treatments in clinical practice: 1) do placebo treatments have the potential to produce clinically significant benefit? and 2) can placebo treatments be effective in promoting a therapeutic placebo response without the use of deception? We examine evidence from clinical trials and laboratory experiments bearing on these two questions. The conclusion is reached that based on currently available evidence, it is premature to judge whether placebo treatments are ethically justifiable, with the possible exception of acupuncture for pain relief.

摘要

医生通常会推荐“安慰剂治疗”,因为人们认为这种治疗方法对患者的病情没有特殊疗效。采用安慰剂治疗的动机包括顺应患者的期望和促进安慰剂效应。在本文中,我们关注两个关键的实证问题,这些问题必须得到解决,以便评估临床实践中安慰剂治疗的伦理合法性:1)安慰剂治疗是否有可能产生临床显著的益处?2)在不使用欺骗手段的情况下,安慰剂治疗能否有效地促进治疗性安慰剂反应?我们考察了与这两个问题相关的临床试验和实验室实验的证据。结论是,根据目前现有的证据,判断安慰剂治疗是否在伦理上是合理的还为时过早,针灸治疗疼痛可能是个例外。

相似文献

1
The legitimacy of placebo treatments in clinical practice: evidence and ethics.安慰剂治疗在临床实践中的合法性:证据与伦理。
Am J Bioeth. 2009 Dec;9(12):39-47. doi: 10.1080/15265160903316263.
2
Response to open peer commentaries on "A duty to deceive: placebos in clinical practice".对关于《欺骗的义务:临床实践中的安慰剂》的公开同行评论的回应。
Am J Bioeth. 2009 Dec;9(12):W1-2. doi: 10.1080/15265160903316412.
3
Is there a place for (deceptive) placebos within clinical practice?(欺骗性)安慰剂在临床实践中有一席之地吗?
Am J Bioeth. 2009 Dec;9(12):52-4. doi: 10.1080/15265160903320455.
4
Placebos in clinical practice and the power of suggestion.临床实践中的安慰剂与暗示的力量。
Am J Bioeth. 2009 Dec;9(12):32-3. doi: 10.1080/15265160903234110.
5
Placebo effects without placebos? More reason to abandon the paradoxical placebo.没有安慰剂的安慰剂效应?更有理由摒弃自相矛盾的安慰剂了。
Am J Bioeth. 2009 Dec;9(12):50-2. doi: 10.1080/15265160903234151.
6
When subtle deception turns into an outright lie.当微妙的欺骗变成彻头彻尾的谎言时。
Am J Bioeth. 2009 Dec;9(12):30-2. doi: 10.1080/15265160903234128.
7
When doctors deceive.当医生进行欺骗时。
Am J Bioeth. 2009 Dec;9(12):29-30. doi: 10.1080/15265160903234102.
8
Physician deception and patient autonomy.医生的欺骗与患者的自主权。
Am J Bioeth. 2009 Dec;9(12):22-3. doi: 10.1080/15265160903244226.
9
Medicine's continuing quest for an excuse to avoid relationships with patients.医学一直在寻找借口以避免与患者建立关系。
Am J Bioeth. 2009 Dec;9(12):13-5. doi: 10.1080/15265160903316313.
10
A duty to deceive: placebos in clinical practice.有欺骗之责:临床实践中的安慰剂。
Am J Bioeth. 2009 Dec;9(12):4-12. doi: 10.1080/15265160903318350.

引用本文的文献

1
A systematic qualitative review of ethical issues in open label placebo in published research.已发表研究中开放标签安慰剂伦理问题的系统定性综述。
Sci Rep. 2025 Apr 10;15(1):12268. doi: 10.1038/s41598-025-96425-5.
2
Noble Humbug? Hard and soft laws on clinical placebo use.高尚的骗局?关于临床安慰剂使用的软硬法律
Front Psychol. 2025 Mar 12;16:1520664. doi: 10.3389/fpsyg.2025.1520664. eCollection 2025.
3
The Placebo Effect in Exercise and Mental Health Research.运动和心理健康研究中的安慰剂效应。
Curr Top Behav Neurosci. 2024;67:381-394. doi: 10.1007/7854_2024_506.
4
Working with patients' treatment expectations - what we can learn from homeopathy.应对患者的治疗期望——我们能从顺势疗法中学到什么。
Front Psychol. 2024 May 27;15:1398865. doi: 10.3389/fpsyg.2024.1398865. eCollection 2024.
5
Acupuncture for Japanese Katakori (Chronic Neck Pain): A Randomized Placebo-Controlled Double-Blind Study.针刺治疗日本 Katakori(慢性颈痛):一项随机安慰剂对照双盲研究。
Medicina (Kaunas). 2023 Dec 9;59(12):2141. doi: 10.3390/medicina59122141.
6
The impact of pharmaceutical form and simulated side effects in an open-label-placebo RCT for improving psychological distress in highly stressed students.药物剂型和模拟副作用对改善高度应激学生心理困扰的开放性安慰剂 RCT 的影响。
Sci Rep. 2023 Apr 19;13(1):6367. doi: 10.1038/s41598-023-32942-5.
7
Open-label placebos-a systematic review and meta-analysis of experimental studies with non-clinical samples.开放性安慰剂-非临床样本的实验研究的系统评价和荟萃分析。
Sci Rep. 2023 Mar 4;13(1):3640. doi: 10.1038/s41598-023-30362-z.
8
A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial.数字化应用和增强型查房可减少初次全膝关节置换术后的疼痛和阿片类药物的使用:一项随机临床试验。
BMC Med. 2022 Dec 5;20(1):469. doi: 10.1186/s12916-022-02638-0.
9
Open-Label Placebo Administration Decreases Pain in Elderly Patients With Symptomatic Knee Osteoarthritis - A Randomized Controlled Trial.开放标签安慰剂给药可减轻有症状的老年膝骨关节炎患者的疼痛——一项随机对照试验。
Front Psychiatry. 2022 May 6;13:853497. doi: 10.3389/fpsyt.2022.853497. eCollection 2022.
10
Attitudes Toward a Pre-authorized Concealed Opioid Taper: A Qualitative Analysis of Patient and Clinician Perspectives.对预先授权的隐匿性阿片类药物减量的态度:患者和临床医生观点的定性分析
Front Psychiatry. 2022 Mar 24;13:820357. doi: 10.3389/fpsyt.2022.820357. eCollection 2022.